ARTL — Artelo Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Artelo Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 August 31st	2020 August 31st	2021 August 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4.42	2.14	10.1	17.5	10.4
Net Total Receivables	0.009	—	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4.44	2.34	10.3	18.3	11
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.001	0	0.09	0.06	0.021
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	6.48	4.38	12.6	20.4	13
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.02	0.502	0.526	0.998	1.29
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.02	0.502	0.593	1.02	1.29
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	5.46	3.87	12	19.4	11.8
Total Liabilities & Shareholders' Equity	6.48	4.38	12.6	20.4	13
Total Common Shares Outstanding